NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Other Accumulated Expenses (2018 - 2026)

NextPlat's (NXPL) quarterly Other Accumulated Expenses came in at $586000.0 in Q2 2026, up 105.61% year-over-year from $285000.0 in Q2 2025, and up 187.25% quarter-over-quarter from $204000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Other Accumulated Expenses for 9 consecutive years, with $586000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 105.61% year-over-year to $586000.0 in Q2 2026; TTM through Jun 2026 was $586000.0, a 105.61% increase from a year earlier, with the FY2025 full-year figure at $287000.0, up 6.69% from the prior year.
  • Other Accumulated Expenses was $586000.0 for Q2 2026 at NextPlat, up from $204000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $586000.0 in Q2 2026 and troughed at $6364.0 in Q2 2022.
  • A 5-year average of $194232.1 and a median of $187500.0 in 2023 frame the typical range for Other Accumulated Expenses.
  • Across the five-year window, Other Accumulated Expenses sank 71.72% in 2022 and soared 1506.03% in 2023, its largest moves.
  • Over 5 years, Other Accumulated Expenses stood at $41000.0 in 2022, then surged by 356.1% to $187000.0 in 2023, then surged by 43.85% to $269000.0 in 2024, then grew by 6.69% to $287000.0 in 2025, then surged by 104.18% to $586000.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $586000.0 (Q2 2026), $204000.0 (Q1 2026), and $287000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 586,000.00
Mar 31, 2026 204,000.00
Dec 31, 2025 287,000.00
Sep 30, 2025 577,000.00
Jun 30, 2025 285,000.00
Mar 31, 2025 277,000.00
Dec 31, 2024 269,000.00
Sep 30, 2024 158,000.00
Jun 30, 2024 188,000.00
Mar 31, 2024 117,000.00
Dec 31, 2023 187,000.00
Sep 30, 2023 239,090.00
Jun 30, 2023 20,000.00
Mar 31, 2023 26,548.00
Dec 31, 2022 41,000.00
Sep 30, 2022 14,887.00
Jun 30, 2022 6,364.00
Mar 31, 2022 13,289.00
Dec 31, 2021 40,305.00
Sep 30, 2021 10,973.00